SOL SpA
MIL:SOL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
25.9
38
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
SOL SpA
SOL SpA
Cash & Cash Equivalents
SOL SpA
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SOL SpA
MIL:SOL
|
Cash & Cash Equivalents
€213m
|
CAGR 3-Years
8%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
SOL SpA
Glance View
In the bustling industrial landscape of Italy, SOL SpA has carved its niche as a pivotal player in the realm of industrial gas and healthcare services. Established in 1927, the company has a rich legacy of innovation and adaptation, supplying essential gases like oxygen, nitrogen, and argon to a variety of industries—ranging from metalwork and electronics to food and beverage. Over the years, SOL expanded its horizons beyond the traditional industrial sector, entering into the healthcare market with a focus on homecare services. This diversification not only amplified its market reach but also cushioned its revenues against the cyclicality typically associated with industrial sectors. SOL SpA's financial success hinges on its dual operating strategy: producing and distributing industrial gases while providing critical healthcare services. In the gases segment, the company boasts a network of advanced production facilities and a sophisticated logistics system, enabling the efficient distribution of these gases across Europe and beyond. Meanwhile, the healthcare segment, which includes home respiratory therapies and medical equipment supplies, ensures a steady stream of income by tapping into the ever-growing demand for at-home medical care. This balanced portfolio allows SOL SpA to maintain a robust revenue stream, harnessing the stability of the healthcare sector while continuing to innovate and serve the dynamic industrial landscape.
See Also
What is SOL SpA's Cash & Cash Equivalents?
Cash & Cash Equivalents
213m
EUR
Based on the financial report for Jun 30, 2024, SOL SpA's Cash & Cash Equivalents amounts to 213m EUR.
What is SOL SpA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
13%
Over the last year, the Cash & Cash Equivalents growth was 71%. The average annual Cash & Cash Equivalents growth rates for SOL SpA have been 8% over the past three years , 13% over the past five years .
You don't have any saved screeners yet